Loading clinical trials...
Loading clinical trials...
To compare the efficacy of two less restrictive dietary therapies - LGIT and MAD, used for treatment of drug resistant epilepsy in children
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
All India Institute of Medical Sciences
NCT06388707 · Drug Resistant Epilepsy, Epilepsy, and more
NCT03268824 · Epilepsies, Focal, Pediatrics, and more
NCT05019885 · Drug Resistant Epilepsy, Medically Refractory Epilepsy, and more
NCT05393518 · Anxiety Disorder, Generalized Anxiety Disorder, and more
NCT06432907 · Drug Resistant Epilepsy, Brain-Computer Interfaces
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi
AIIMS
New Delhi, National Capital Territory of Delhi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions